EXAS — Exact Sciences Balance Sheet
0.000.00%
Last trade - 00:00
- $11.07bn
- $12.67bn
- $2.50bn
- 67
- 18
- 38
- 36
C2019 December 31st | C2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Cash | |||||
Cash and Equivalents | |||||
Short Term Investments | |||||
Cash and Short Term Investments | 324 | 1,840 | 1,030 | 632 | 778 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 130 | 233 | 217 | 158 | 204 |
Total Inventory | |||||
Prepaid Expenses | |||||
Total Current Assets | 554 | 2,199 | 1,426 | 982 | 1,194 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 582 | 597 | 773 | 862 | 853 |
Net Goodwill | |||||
Net Intangible Assets | |||||
Other Long Term Assets | |||||
Total Assets | 3,506 | 4,925 | 6,685 | 6,227 | 6,471 |
Accounts Payable | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 236 | 633 | 517 | 413 | 515 |
Long Term Debt | |||||
Capital Lease Obligations | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Total Other Liabilities | |||||
Total Liabilities | 1,218 | 2,690 | 3,297 | 3,184 | 3,326 |
Non Redeemable Preferred Stock | |||||
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Unrealized Gain / Loss | |||||
Other Equity | |||||
Total Equity | 2,288 | 2,236 | 3,388 | 3,043 | 3,145 |
Total Liabilities & Shareholders' Equity | 3,506 | 4,925 | 6,685 | 6,227 | 6,471 |
Total Common Shares Outstanding |